Contact

Merge Healthcare Continues Sales Momentum For Clinical Trials Solutions With Seven New Contracts In January Merge has started off 2011 with seven new contracts for its clinical trials solutions. These wins reflect continued momentum across all the clinical trials applications, and represent both new and expanded customer relationships.

Merge Healthcare Continues Sales Momentum For Clinical Trials Solutions With Seven New Contracts In January

.

Merge Healthcare (NASDAQ: MRGE), a global corporation dedicated to health IT interoperability solutions, today announced that the company has started the year off with seven new contracts for its clinical trials solutions. These wins reflect continued momentum across all the clinical trials applications, and represent both new and expanded customer relationships.

“We have enjoyed a long-standing partnership with Merge Healthcare for their clinical trial solutions,” noted Allen Cato, M.D., Ph.D., and CEO of Cato Research Ltd., a Contract Research Organization (CRO) based in Research Triangle Park, NC, “and we are pleased to expand our relationship to include Merge’s myEDC™ as a cost effective solution for our early phase trials. This month we took our first myEDC study live, and have already documented improvements in the quality and accessibility of data. myEDC allows us to quickly build the custom capabilities our Sponsors need and to provide a complete view of the information in real-time.”

In addition to the customizable myEDC platform, the Merge solution set for clinical trials includes applications for enterprise Electronic Data Capture (EDC), Interactive Voice and Web Response (IVR/IWR), electronic Patient Reported Outcomes (ePRO) via internet, phone or handheld device, and an endpoint adjudication module. The Merge CIMS platform for managing the imaging component of clinical trials was recently awarded Frost and Sullivan’s 2010 Healthcare Innovation for Medical Imaging Workflow Solutions of the Year. Merge capabilities extend across all stages of clinical trials, international studies, and many clinical specialty trials. The Merge suite of clinical trials solutions will be available for demonstration at the upcoming HIMSS conference February 20 – 24 in Orlando, Florida. Merge can be found at booth #3348.

“We’re thrilled with the recent momentum for this solution set,” said Jeff Surges, Merge CEO. “Clinical trials need efficient electronic workflow via an intuitive interface, and broad interoperability among associated applications, and imaging is a particular challenge. Just as with our iConnect platform for healthcare providers, Merge brings a new value proposition to these customers, and the recent wins show that the clinical trials market recognizes this.”

Merge Healthcare Incorporated develops and integrates information technology to create a better electronic healthcare experience. Merge products, ranging from standards-based development toolkits to sophisticated clinical applications, have been used by healthcare providers, vendors and researchers worldwide for over 20 years. Additional information can be found at www.merge.com.

Press Contact:
Brenda Stewart
Director of Marketing Communications
312-540-6622
brenda.stewart@merge.com

 

© 2017 IBM Watson Health. All Rights Reserved. Privacy | Terms | Email Signup | Sitemap